Treatment of COVID-19 bacterial superinfections | Pandemic PACT Tracker

Key facts

Disease
COVID-19
Start & end year
2020
2020
Known Financial Commitments (USD)
$17,700
Funder
Innosuisse
Principal Investigator
Katja Becker
Research Location
Switzerland
Lead Research Institution
Universität Zürich - ZH
Research Priority Alignment
N/A

Research Category
Therapeutics research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified

Abstract

Treatment of COVID-19 bacterial superinfections

Publicationslinked via Europe PMC

Last Updated:2 days ago

View all publications at Europe PMC

Antimicrobial susceptibility patterns of respiratory Gram-negative bacterial isolates from COVID-19 patients in Switzerland.